|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 348.00 EUR | +1.61% |
|
-0.57% | -2.66% |
| 05-11 | Virbac continues decline despite positive recommendation |  |
| 04-17 | Virbac: 2026 starts on strong footing |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VIRBAC | Veterinary Drugs | +1.61% | -0.57% | -2.66% | +9.09% | +30.09% | 3.38B |  |  |  |
- Stock Market
- Stocks
- VIRP Stock
- Charts Virbac
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
